Composition and method for the prevention and relief of the symptoms of an incompetent or patulous Eustachian tube
View Patent ↗A composition and methods for the treatment of symptoms due to disorders, disease or trauma that impairs normal function of die Eustachian tube and alters vital structures or tissues of the middle ear. This includes diseases and disorders of the Eustachian tube altered by tubal incompetence, inflammatory phenomenon as rhinitis, nasal allergies, infections by microorganisms, tympanic membrane rupture or trauma and variants. The composition is comprised of solution including L-Ascorbic acid and a pharmaceutically acceptable liquid carrier and delivery system. The administration of which is applied topically in appropriate composition and dosage for intranasal or trans tympanic route in the form of drops, spray, aerosol, rinse, douche, gel, or devices.
1. A method of treating the patulous Eustachian tube syndrome, a severe variant, of Eustachian tube incompetence, comprising:
applying to a person's nasal mucosa a composition of L-Ascorbic acid, in a highly acidic concentration of about 5% to about 20% wt/vol, within a range of about 2.4 to 2.0 pH level, in an aqueous solution, and a pharmaceutically acceptable liquid carrier and delivery system.
2. A method according to claim 1 in which the solution is applied topically to the nasal mucosa by positioning the person's head between 45 to 60 degrees above horizontal and turned 45 to 60 degrees toward an ear affected by patulous Eustachian tube syndrome thereby placing the Eustachian tube stoma lower than the nostril.
3. A method according to claim 1 in which the solution is applied to the middle ear chamber.
4. A method according to claim 2 in which the solution is applied in drops into the nose.
5. A method according to claim 2 in which the solution is applied in a spray into the nose.
6. A method according to claim 2 in which the solution is applied in an aerosol into the nose.
7. A method according to claim 1 in which the solution is applied topically via an ET catheter to the nasopharyngeal stoma of the Eustachian tube.
8. A method according to claim 3 in which the solution is applied to the middle ear employing a syringe and needle.
9. A method according to claim 3 in which the solution is applied to the middle ear employing a trans-tympanic membrane puncture.
10. A method according to claim 3 in which the solution is applied to the middle ear employing a myringotomy.
11. A method according to claim 3 in which the solution is delivered by employing an implanted device to or in the middle ear chamber.
12. A method according to claim 3 in which a porous device is implanted within a defect of the tympanic membrane or the middle ear chamber.
13. A method according to claim 11 in which the solution is applied to the porous device.
14. A method according to claim 1 in which the liquid carrier is distilled water.
15. A method according to claim 1 in which the L-ascorbic acid is L-3-keto threo hexuronic acid lactone and the solution has a pH in the range of about 2.2 pH to about 2.0 pH level.
16. A method according to claim 1 in which the L-Ascorbic acid is present in the carrier at a concentration from about 10% to about 20% wt./volume.
17. A method according to claim 8 in which the solution further comprises distilled water.
18. A method according to claim 1 in which the composition includes an antioxidant.
19. A method according to claim 18 wherein the antioxidant is a flavone, bioflavonoid, in a concentration of about 0.1 to 0.5% wt/vol.
20. A method according to claim 18 wherein the antioxidant is Tocopherol.
21. A method according to claim 18 wherein the antioxidant is water solubilized vitamin E (alpha-tocopherol) in a concentration of about 500 to 1,000 i.u./100 m.